Remove Medicine Remove Networking Remove Pharmaceutical manufacturing Remove Pharmaceutical products
article thumbnail

Strengthening and transforming the pharmaceutical supply chain

European Pharmaceutical Review

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. What types of medicinal products are in short supply and why?

article thumbnail

New IFPMA and EFPIA guidance on use of social media by the pharmaceutical industry

pharmaphorum

Digital channels are defined as “ platforms for electronic communication through transmission of digital content over the internet or computer networks. The Guidance applies to both product-related and therapeutic-area-related activities. Why is guidance needed? Digital Channels include, but are not limited to, social media ”.

Media 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Tackling fake pharmaceuticals: an industry united against counterfeit products

European Pharmaceutical Review

As the world now looks to a post-pandemic future, despite the counterfeit medicine trade showing no signs of slowing, industry bodies must come together to tackle the production and trade of fake products. This vicious circle is driving increasing demand for cheaper, less-regulated medicines.

article thumbnail

Using big data to stabilise pharma supply chains in an age of disruption

Pharmaceutical Technology

In an age of disruption, technology is key to enabling pharmaceutical manufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised. Cold chain shipments are particularly vulnerable.

Pharma 52